Pulmonary Mycobacterium kyorinense disease showed clinical improvement following combined therapy with clarithromycin and levofloxacin

Internal Medicine

Volumn 51, Issue 14, 2012, Pages 1923-1926

  Kobashi, Yoshihiro ^a   Mouri, Keiji ^a   Obase, Yasushi ^a   Kato, Shigeki ^a   Oka, Mikio ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Clarithromycin; Levofloxacin; Mycobacterium kyorinense

Indexed keywords

AMIKACIN; CLARITHROMYCIN; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; RIFAMPICIN; RNA 16S; STREPTOMYCIN;

ACID FAST BACTERIUM; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; FEVER; GENE SEQUENCE; HUMAN; INFLAMMATION; LUNG DISEASE; LUNG INFILTRATE; MALE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM; MYCOBACTERIUM KYORINENSE; PHYLOGENY; SPUTUM CULTURE; THORAX RADIOGRAPHY;

ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; HUMANS; LEVOFLOXACIN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; OFLOXACIN; TUBERCULOSIS, PULMONARY;

EID: 84864041688     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.6431     Document Type: Article

References (8)

1. Okazaki M, Ohkusu K, Hata H, et al. Mycobacterium kyorinense sp. nov., a novel, slow-growing species, related to Mycobacterium celatum, isolated from human clinical specimens. Int J Syst Evol Microbiol 59: 1336-1341, 2009.
2. Wada H, Yamamoto M, Okazaki M, Watanabe T, Goto H. Isolation of Mycobacterium kyorinense in a patient with respiratory failure. Ann Intern Med 150: 568-570, 2009.
3. García-Garrote F, Ruiz-Serrano MJ, Cosin J, Alcalá L, Ortega A, Bouza E. Mycobacterium celatum as a cause of disseminated infection in an AIDS patient. Clin Microbiol Infect 3: 582-584, 1997.
4. Brander E, Jantzen E, Huttunen R, Julkunen A, Katila ML. Characterization of a distinct group of slowly growing mycobacteria by biochemical tests and lipid analyses. J Clin Microbiol 30: 1972-1975, 1992.
5. Butler WR, O'Connor SP, Yakrus MA, et al. Mycobacterium celatum sp. nov. Int J Syst Bacteriol 43: 539-548, 1993.
6. Sugawara I, Kazumi Y, Otomo K, Ooki K, Mitarai S, Mori K. Mycobacterium branderi isolated from pus of a right pulmonary cavitary lesion. Jpn J Infect Dis 58: 187-188, 2005.
7. Bux-Gewehr I, Hagen HP, Rüsch-Gerdes S, Feurle GE. Fatal pulmonary infection with Mycobacterium celatum in an apparently immunocompetent patient. J Clin Microbiol 36: 587-588, 1998.
8. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/ IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175: 367-416, 2007.